About this trial
This randomized controlled clinical trial aims to evaluate and compare the effectiveness of lavender essential oil and bitter orange essential oil aromatherapy in reducing dental anxiety and pain in children during the administration of local anesthesia. Children aged 6-12 years undergoing dental procedures requiring local anesthetic infiltration will be randomly assigned to lavender aromatherapy, bitter orange aromatherapy, or placebo (empty inhaler). Dental anxiety will be assessed using pulse rate and blood pressure measurements, while pain will be evaluated using the FLACC behavioral pain scale. The findings are expected to provide evidence on the role of aromatherapy as a non-pharmacological, safe, and cost-effective behavior guidance method in pediatric dentistry.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children with the age range of 6-12 years
Any dental procedure that requires injection of local anesthesia.
Cooperative patients.(according to Frankl's classification class 1 and 2)
Parents or guardians willing to participate in the study.
Disqualifiers
Children with complicated systemic disease.
Uncooperative patients. .(according to Frankl's classification class 3 and 4)
Children with severe cognitive impairment or developmental disorders
Children with respiratory tract infections.
Trial design
Crossover
Treatments tested in this trial
Lavender essential oil in the inhaler
BehavioralThe children will be asked to inhale the aroma (Lavender) from the inhalers for 2 minutes before local anesthetic agent injection to reduce pain and anxiety.
Bitter Orange essential oil in the inhaler
BehavioralThe children will be asked to inhale the aroma ( bitter Orange) from the inhalers for 2 minutes before local anesthetic agent injection to reduce pain and anxiety.
Epmty inhaler (Placebo)
BehavioralThe children will be asked to inhale from an empty inhaler for 2 minutes before local anesthetic agent injection.
Treatment groups
Trial outcomes
Primary outcomes
Anxiety level (objective)
tool: pulse oximeter unit: beats per minute
Secondary outcomes
anxiety level (objective)
tool: digital blood pressure monitor, unit: systolic/diastolic mmhg
pain assessment
assessment of pain by FLACC (face-leg-activity-cry-consolability) scale score (0-2) (0 is the best outcome) (2 is the worst)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: